Novadaq Technologies, Inc. Launches PINPOINT: Company’s First Minimally Invasive Imaging System

TORONTO, Oct. 16 /CNW/ - Novadaq(R) Technologies Inc. (TSX: NDQ), a developer of real-time medical imaging systems and image guided therapies for the operating room, today announced that it will launch the PINPOINT(TM) endoscopic imaging system at the Annual Meeting of American College of Chest Physicians (ACCP), CHEST 2007, to be held in Chicago, IL, October 22nd - 25th, 2007. PINPOINT is based upon the endoscopic technology Novadaq acquired from Xillix Technologies Inc., and is designed to not only perform white light bronchoscopy, but also the more clinically relevant imaging commonly referred to as autofluorescence and narrow band imaging. Many studies have shown autofluorescence to be more effective in the detection and localization of central airway cancers than conventional white light bronchoscopy. The ACCP Evidence Based Practice Guidelines now recommend the use of autofluorescence bronchoscopy for the localization of certain lung cancers, for guiding endoluminal therapies, and as a surveillance tool in patients with pre-invasive disease.